Carillon Tower Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3.99M	Buy	158,677 +1,200	+0.8%	+$25.8K	0.02%	426
2020 Q3	$3.28M	Buy	157,477 +20,742	+15%	+$471K	0.04%	375
2020 Q2	$3.25M	Sell	136,735 -3,800	-3%	-$84K	0.03%	404
2020 Q1	$2.53M	Sell	140,535 -13,600	-9%	-$286K	0.02%	389
2019 Q4	$3.66M	Sell	154,135 -185,775	-55%	-$4.51M	0.02%	417
2019 Q3	$9.34M	Sell	339,910 -86,300	-20%	-$2.56M	0.07%	337
2019 Q2	$14.1M	Sell	426,210 -136,150	-24%	-$4.66M	0.1%	291
2019 Q1	$19.7M	Sell	562,360 -60,100	-10%	-$2.24M	0.14%	244
2018 Q4	$20.7M	Buy	622,460 +233,125	+60%	+$10M	0.18%	211
2018 Q3	$19.6M	Sell	389,335 -48,165	-11%	-$2.38M	0.14%	237
2018 Q2	$26.2M	Buy	437,500 +268,025	+158%	+$13.9M	0.21%	175
2018 Q1	$7.76M	Buy	+169,475	New	+$7.07M	0.06%	332